NEW YORK CITY (WABC) -- It could be a game changer in COVID 19 testing: A company with offices in the Tri-State area received emergency authorization from the FDA for a test that could get results ...
July 17 (Reuters) - Abbott (ABT.N), opens new tab warned on Thursday it expects more than $1 billion in financial headwinds this year from a sharp decline in COVID-19 testing demand, new U.S. tariffs, ...
Forbes contributors publish independent expert analyses and insights. Bruce Japsen writes about healthcare business and policy. Abbott Laboratories $21 billion deal to acquire cancer test maker Exact ...
Medical devices continue to be a strong growth driver for Abbott, as the company battles its ongoing sales slump in diagnostics, which accelerated in the third quarter. Third-quarter revenue for its ...
The Food and Drug Administration issued a warning late Thursday over the accuracy of the highly-touted Abbott instant coronavirus test. Specifically, the FDA said that the test has caused some false ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback